HOME >> MEDICINE >> NEWS
Diabetes drug improves metabolic changes associated with HIV combination therapy

Use of an oral antidiabetes medication produced significant improvement in a group of patients with HIV lipodsytrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection. In the May 18 Annals of Internal Medicine, researchers from Massachusetts General Hospital (MGH) report that daily doses of rosiglitazone (Avandia) improved insulin sensitivity and alleviated fat redistribution in patients with lipodystrophy and insulin resistance.

The drug combination strategy known as highly active antiretrovial therapy (HAART) can significantly reduce viral levels and help maintain health in HIV-infected individuals, but a significant number can develop lipodystrophy. Typical symptoms of the syndrome may include a loss of subcutaneous fat in the face, arms, and legs; increased fat deposits in the abdomen and upper back; changes in cholesterol and other blood lipids; and insulin resistance.

"The metabolic complications of this condition are becoming more significant as patients spend more time on HAART," says Colleen Hadigan, MD, MPH, of the MGH Neuroendocrine Unit and Program in Nutritional Metabolism, the report's lead author. "For example, we now know that 14 percent of men on this therapy may develop type 2 diabetes, which is four times the usual risk; and concerns are also increasing about the related risk of heart disease."

Although previous studies have examined the effect of rosiglitazone and similar medications on HIV lipodystrophy, the results have been inconclusive. Since patients with the syndrome may have a variety of associated symptoms, the current study was limited to participants who had developed insulin resistance. The 27 enrolled patients were randomized to receive daily doses of either rosiglitazone or a placebo, and neither participants nor the researchers knew who was receiving the active medication.

At the end of the three-month
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
17-May-2004


Page: 1 2

Related medicine news :

1. Diabetes a bigger heart disease risk for women than for men
2. Diabetes: A link between oral and overall health?
3. Diabetes among older adults imposed an estimated $133.5 billion cost in 1990s
4. Diabetes increases deaths among people 65 and older
5. Diabetes may be going unnoticed in many UK children
6. Diabetes linked to increased risk of Alzheimers in long-term study
7. Diabetes patients skip medications to save money
8. Diabetes doubles risk of liver disease and liver cancer
9. Salk news: Diabetes first steps
10. Diabetes management improves when patients, doctors agree on treatment goals, UMHS study finds
11. Diabetes patients with low literacy more likely to have poorly controlled disease

Post Your Comments:
(Date:7/7/2015)... ... July 07, 2015 , ... ... stores throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised ... surpassing their original 2015 fundraising goal by nearly $100,000, to help support ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... MRI services, is debuting their brand new website. The website’s goal is to ... a wider selection of patient tools, including requesting appointments online. , Part of ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today ... website that helps active people find the most fun activities to do with friends. ... for millennials. It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading ... aims to give back to the community through company-wide volunteering efforts. , On an ... dedicate the day to assisting those in need throughout Baltimore and Washington D.C. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time to get outside ... is sharing some safety tips. , Jean Tapley, senior wellness coordinator at Amica, suggests ... , Start slowly. Going from no activity to several hours of ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
(Date:7/7/2015)... , 7. Juli 2015 BioClinica®, ... für klinische Studien, gab heute bekannt, dass es ... Unternehmen bei Gewinnung und Erhalt von Patienten übernommen ... MediciGlobal , Ltd. und Access to Patients, ... einen Dienst zum Auffinden von Patienten, die für ...
(Date:7/7/2015)... , July 7, 2015 /PRNewswire/ -- Mindray Medical ... leading developer, manufacturer and marketer of medical devices ... the remaining stake in Wuhan Dragonbio Surgical Implant ... Dragonbio is a domestic medical orthopedic-product ... other surgical products. Prior to today,s announcement, Mindray ...
(Date:7/7/2015)... , July 7, 2015 Oasmia ... drugs within human and veterinary oncology, has filed a ... Exchange Commission, in connection with the proposed public offering ... Market. The number of American Depositary Shares, representing ordinary ... the offering have not yet been determined. An Investor ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2
Cached News: